Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. - Wikidata - wikimedia - TriplyDB

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.

http://www.wikidata.org/entity/Q34711600

about

Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma MIBG scintigraphy and PET imaging for diagnosing neuroblastoma Outcome after reduced chemotherapy for intermediate-risk neuroblastoma Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.Identification of a novel zinc finger gene, zf5-3, as a potential mediator of neuroblastoma differentiation.Rac GTPase regulation of 3D invasion in neuroblastomas lacking MYCN amplification.Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.Metastatic congenital neuroblastoma associated with in situ neuroblastoma: case report and review of literature.N-myc gene product expression in neuroblastoma.Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.Paediatric urological malignancies.Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation.Neuroblastoma in adults and adolescents: an indolent course with poor survival.Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.Neonatal tumours: Glasgow 1955-86.A comparison of current neuroblastoma chemotherapeutics.Clinical significance of NTRK family gene expression in neuroblastomas Neuroblastoma in the very young child: biological considerations.Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells

P2860

Q24186451-34CB777D-F28D-4A23-A7B5-39C125BA30C5 Q24186636-87D33CAC-3396-476C-B259-D78CEB0E7D8C Q24186888-F94F2382-6E59-446F-B013-2E91ACC5E538 Q24200296-1888FDCF-FBC6-408E-943A-6BD386858186 Q24234571-1987D293-CACD-4B2A-9CC2-7A7B7642EC33 Q24633964-CA9E3663-A877-4883-861B-6068D26EE31E Q24647476-CDAA07B4-034B-4807-8510-32CA46287830 Q28281864-92051886-697F-4BBD-90AB-4DF2527E9E94 Q28364926-FA2E664B-664F-45EA-831D-28DB67E12F1A Q28474594-D98E4D7A-5D03-4AAE-9298-90AA04F32729 Q30639268-05414BEE-1DA4-48AC-80B4-C07EE334AE92 Q30711268-AE9FFFD9-AE5D-45F0-B6A2-3C64C7B50BCC Q30838566-D039A71F-5012-47CD-AC09-15067E196D6D Q33275966-F6B5E27C-08E1-48DA-A428-5A73C1EEFA8C Q33738022-F1E5AEE1-F308-463A-AF2D-7F5C6CF0DE76 Q33839777-BC206458-6A2F-474C-BB88-763D8DBBC3FC Q33946117-1B32BE36-20DB-46FD-8AE2-E455D6C5A0D3 Q33999779-6A5B629A-59D3-4209-98C2-E9DAB54DBBD4 Q34032495-C32EE9A2-20F7-4380-8197-D6FFF17D23F9 Q34066263-8DF2AD7E-F5B1-4E85-9785-C9156DEB4BB9 Q34249635-5EF7EDB7-5C85-470C-B611-D93207642B0B Q34251061-D4426950-6FFD-46A5-91BE-75F0E14E9216 Q34314320-89B078F8-EE01-4149-A3DC-D904F1386E8B Q34373947-D2A4E26A-6873-45A2-8181-4D8BE9A9ACC4 Q34425936-EF327C8E-A51B-4BDA-96AF-BF6B8C62738A Q34580464-F2DD77E9-05A2-4E70-A186-82C1F31B3035 Q34662881-7B5B45AC-B151-42E2-A76A-D2A65AC67060 Q34770201-C6A44B9A-5B82-4CDE-A51A-90885E8335DE Q34956841-D3389A0A-5C5F-4381-AA7F-ADB24F44F8C7 Q35083674-E87B8846-4842-44E5-95AB-6D45B1845631 Q35122169-10077C14-4691-4543-B254-6BD26EDAD70A Q35178612-980D223A-7609-4EEB-B2DF-84A9B3F653EA Q35597039-DFDFF6F6-522E-4D77-8C86-CA9F21724DAE Q35605017-D8BFF6E5-F3F1-4825-BFDC-C08732A49C8F Q35609684-80C35043-9904-440E-8EB6-205C4F7DEFCD Q35673178-87730283-B378-4F0D-9769-CB0DDEDB5F65 Q35708386-33F3BF93-CDC4-42DC-A2E2-B810734895C1 Q35747067-F998122C-0DE0-4C29-BC96-3B0BF8F1D51E Q35763574-6CC4291A-DABF-400D-A92B-40C99B5354E8 Q35764470-883472CE-F32F-4332-8287-18A93E862C79

P2860

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.

http://www.wikidata.org/entity/Q34711600

description

1984 nî lūn-bûn

@nan

1984 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1984 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

name

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@ast

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@en

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@nl

type

label

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@ast

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@en

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@nl

prefLabel

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@ast

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@en

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@nl

P1433

Q34711600-6334F073-4715-4A55-9861-4589F152A093

P1476

Q34711600-F7E722C1-439F-4829-B1BA-3E63439C06DF

P2093

Q34711600-04EA3C9C-2B5A-4AB3-ACEB-746099EA3404

Q34711600-09260C02-1969-4FE2-9EE6-36AA2D1D3056

Q34711600-0B878215-CB56-4C73-9850-13EB3623D1AE

Q34711600-11536BF8-F8E7-4E46-A0E1-70AADC189576

Q34711600-246468F7-1CF7-44C4-9F47-65460A3F33F2

Q34711600-96B29A9B-6333-4C54-B8D9-E2A76F4A16CF

Q34711600-E067D591-A90D-4E28-8E29-A276C6A4F2BF

Q34711600-E95AABAC-0055-4316-A7AB-950941ECB7FE

P304

Q34711600-0D8933B3-D723-42D8-AA36-0A35A4B40C0A

P31

Q34711600-D8652C29-46E1-4833-A53C-FA0356271349

P356

Q34711600-02210CAB-8E81-429E-A79F-907DCB9BB51D

P407

Q34711600-8F0AFB92-2790-4A25-BED3-3BDD86BD765D

P433

Q34711600-DA59DBDF-77C9-43E5-9263-D7F2E1107FBB

P478

Q34711600-3E4DDB0F-FA5F-430E-8E21-679A873A770A

P577

Q34711600-5229E1F8-9231-4F4C-8117-357EDDA10333

P698

Q34711600-A5A30D1E-6F81-4428-9939-287C046E306F

P356

P1433

Journal of the National Cancer Institute

P1476

Histopathologic prognostic fac ...... ssification of neuroblastomas.

@en

P2093

Chatten J

http://www.w3.org/2001/XMLSchema#string

Chiba T

http://www.w3.org/2001/XMLSchema#string

Hamoudi AB

http://www.w3.org/2001/XMLSchema#string

Marsden HB

http://www.w3.org/2001/XMLSchema#string

Misugi K

http://www.w3.org/2001/XMLSchema#string

Newton WA Jr

http://www.w3.org/2001/XMLSchema#string

Sachs N

http://www.w3.org/2001/XMLSchema#string

Shimada H

http://www.w3.org/2001/XMLSchema#string

P304

405-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/73.2.405

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1984-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6589432

http://www.w3.org/2001/XMLSchema#string